International Stem Cell Corporation

ISCO ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $5.2M

Liabilities Breakdown FY2024

Total Liabilities: $4.8M